This educational activity is intended for an international audience of non-US rheumatologists, pulmonologists, allergists, and clinical immunologists.
The treatment landscape for patients with SSc-ILD is evolving. Physicians have a critical need to understand the pathogenesis of SSc-ILD, the rationale and mode of action for the development of new treatments, and the efficacy and safety profiles of current and emerging therapies.
Upon completion of this activity, participants will have increased knowledge regarding the:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 8/29/2018
Valid for credit through: 8/29/2019, 11:59 PM EST
processing....
All sections of this activity are required for credit.
The treatment landscape for patients with SSc-ILD is evolving. Physicians have a critical need to understand the pathogenesis of SSc-ILD, the rationale and mode of action for the development of new treatments, and the efficacy and safety profiles of current and emerging therapies.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.